CiteFacts · FDA Drug Shortages · FDA source

Promethazine Hydrochloride Injection

FDA shortage status · Source checked 2026-08-22T15:54:11+00:00

Status

FDA currently lists this ingredient in shortage.

This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.

FDA package and manufacturer records

CompanyPresentationFDA availability fieldFDA update
Hikma Pharmaceuticals USA, Inc.Phenergan, Injection, 25 mg/1 mL (NDC 0641-6082-25)Available08/13/2026
Hikma Pharmaceuticals USA, Inc.Phenergan, Injection, 25 mg/1 mL (NDC 0641-6084-25)Unavailable08/13/2026
Hikma Pharmaceuticals USA, Inc.Phenergan, Injection, 50 mg/1 mL (NDC 0641-6083-25)Unavailable08/13/2026
Hikma Pharmaceuticals USA, Inc.Phenergan, Injection, 50 mg/1 mL (NDC 0641-6085-25)Available08/13/2026
Hikma Pharmaceuticals USA, Inc.Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-0928-25)Unavailable08/13/2026
Hikma Pharmaceuticals USA, Inc.Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-1495-35)Available08/13/2026
Hikma Pharmaceuticals USA, Inc.Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-0929-25)Available08/13/2026
Hikma Pharmaceuticals USA, Inc.Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-1496-35)Unavailable08/13/2026
XGen Pharmaceuticals DJB, Inc.Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 39822-5525-3)Available06/23/2026
XGen Pharmaceuticals DJB, Inc.Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 39822-5550-6)Unvailable06/23/2026

Source facts

Grouped generic ingredient: Promethazine Hydrochloride Injection · 10 package records · Latest FDA row update: 08/13/2026

Therapeutic categories: Analgesia/Addiction, Gastroenterology, Other, Pediatric, Pulmonary/Allergy
Dosage forms: Injection
Routes: INTRAMUSCULAR, INTRAVENOUS

Open FDA source data · JSON · Markdown

FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.